Global and United States Vial and Prefilled Syringe Market Report & Forecast 2024-2031

Report ID: 1862907 | Published Date: Jan 2025 | No. of Page: 117 | Base Year: 2024 | Rating: 4.2 | Webstory: Check our Web story
1 Study Coverage
    1.1 Vial and Prefilled Syringe Product Introduction
    1.2 Global Vial and Prefilled Syringe Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Vial and Prefilled Syringe Sales in US$ Million for the Year 2017-2028
        1.2.2 Global Vial and Prefilled Syringe Sales in Volume for the Year 2017-2028
    1.3 United States Vial and Prefilled Syringe Outlook 2017 VS 2022 VS 2028
        1.3.1 United States Vial and Prefilled Syringe Sales in US$ Million for the Year 2017-2028
        1.3.2 United States Vial and Prefilled Syringe Sales in Volume for the Year 2017-2028
    1.4 Vial and Prefilled Syringe Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.4.1 The Market Share of United States Vial and Prefilled Syringe in Global, 2017 VS 2022 VS 2028
        1.4.2 The Growth Rate of Vial and Prefilled Syringe Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.5 Vial and Prefilled Syringe Market Dynamics
        1.5.1 Vial and Prefilled Syringe Industry Trends
        1.5.2 Vial and Prefilled Syringe Market Drivers
        1.5.3 Vial and Prefilled Syringe Market Challenges
        1.5.4 Vial and Prefilled Syringe Market Restraints
    1.6 Study Objectives
    1.7 Years Considered
2 Market by Type
    2.1 Vial and Prefilled Syringe Market Segment by Type
        2.1.1 Glass Vial and Prefilled Syringe
        2.1.2 Polymer Vial and Prefilled Syringe
    2.2 Global Vial and Prefilled Syringe Market Size by Type
        2.2.1 Global Vial and Prefilled Syringe Sales in Value, by Type (2017, 2022 & 2028)
        2.2.2 Global Vial and Prefilled Syringe Sales in Volume, by Type (2017, 2022 & 2028)
        2.2.3 Global Vial and Prefilled Syringe Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    2.3 United States Vial and Prefilled Syringe Market Size by Type
        2.3.1 United States Vial and Prefilled Syringe Sales in Value, by Type (2017, 2022 & 2028)
        2.3.2 United States Vial and Prefilled Syringe Sales in Volume, by Type (2017, 2022 & 2028)
        2.3.3 United States Vial and Prefilled Syringe Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
    3.1 Vial and Prefilled Syringe Market Segment by Application
        3.1.1 Antithrombotics
        3.1.2 Vaccines
        3.1.3 Autoimmune Diseases
        3.1.4 Anti-inflammatory Drugs
        3.1.5 Others
    3.2 Global Vial and Prefilled Syringe Market Size by Application
        3.2.1 Global Vial and Prefilled Syringe Sales in Value, by Application (2017, 2022 & 2028)
        3.2.2 Global Vial and Prefilled Syringe Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 Global Vial and Prefilled Syringe Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    3.3 United States Vial and Prefilled Syringe Market Size by Application
        3.3.1 United States Vial and Prefilled Syringe Sales in Value, by Application (2017, 2022 & 2028)
        3.3.2 United States Vial and Prefilled Syringe Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 United States Vial and Prefilled Syringe Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Vial and Prefilled Syringe Competitor Landscape by Company
    4.1 Global Vial and Prefilled Syringe Market Size by Company
        4.1.1 Top Global Vial and Prefilled Syringe Manufacturers Ranked by Revenue (2021)
        4.1.2 Global Vial and Prefilled Syringe Revenue by Manufacturer (2017-2022)
        4.1.3 Global Vial and Prefilled Syringe Sales by Manufacturer (2017-2022)
        4.1.4 Global Vial and Prefilled Syringe Price by Manufacturer (2017-2022)
    4.2 Global Vial and Prefilled Syringe Concentration Ratio (CR)
        4.2.1 Vial and Prefilled Syringe Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Vial and Prefilled Syringe in 2021
        4.2.3 Global Vial and Prefilled Syringe Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Vial and Prefilled Syringe Manufacturing Base Distribution, Product Type
        4.3.1 Global Vial and Prefilled Syringe Manufacturers, Headquarters and Distribution of Producing Region
        4.3.2 Manufacturers Vial and Prefilled Syringe Product Type
        4.3.3 Date of International Manufacturers Enter into Vial and Prefilled Syringe Market
    4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    4.5 United States Vial and Prefilled Syringe Market Size by Company
        4.5.1 Top Vial and Prefilled Syringe Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Vial and Prefilled Syringe Revenue by Players (2020, 2021 & 2022)
        4.5.3 United States Vial and Prefilled Syringe Sales by Players (2020, 2021 & 2022)
5 Global Vial and Prefilled Syringe Market Size by Region
    5.1 Global Vial and Prefilled Syringe Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Vial and Prefilled Syringe Market Size in Volume by Region (2017-2028)
        5.2.1 Global Vial and Prefilled Syringe Sales in Volume by Region: 2017-2022
        5.2.2 Global Vial and Prefilled Syringe Sales in Volume Forecast by Region (2023-2028)
    5.3 Global Vial and Prefilled Syringe Market Size in Value by Region (2017-2028)
        5.3.1 Global Vial and Prefilled Syringe Sales in Value by Region: 2017-2022
        5.3.2 Global Vial and Prefilled Syringe Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Vial and Prefilled Syringe Market Size YoY Growth 2017-2028
        6.1.2 North America Vial and Prefilled Syringe Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Vial and Prefilled Syringe Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Vial and Prefilled Syringe Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 China Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
    6.3 Europe
        6.3.1 Europe Vial and Prefilled Syringe Market Size YoY Growth 2017-2028
        6.3.2 Europe Vial and Prefilled Syringe Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Vial and Prefilled Syringe Market Size YoY Growth 2017-2028
        6.4.2 Latin America Vial and Prefilled Syringe Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Vial and Prefilled Syringe Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Vial and Prefilled Syringe Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 UAE
7 Company Profiles
    7.1 BD (US)
        7.1.1 BD (US) Corporation Information
        7.1.2 BD (US) Description and Business Overview
        7.1.3 BD (US) Vial and Prefilled Syringe Sales, Revenue and Gross Margin (2017-2022)
        7.1.4 BD (US) Vial and Prefilled Syringe Products Offered
        7.1.5 BD (US) Recent Development
    7.2 Gerresheimer (DE)
        7.2.1 Gerresheimer (DE) Corporation Information
        7.2.2 Gerresheimer (DE) Description and Business Overview
        7.2.3 Gerresheimer (DE) Vial and Prefilled Syringe Sales, Revenue and Gross Margin (2017-2022)
        7.2.4 Gerresheimer (DE) Vial and Prefilled Syringe Products Offered
        7.2.5 Gerresheimer (DE) Recent Development
    7.3 Nipro Corporation (JP)
        7.3.1 Nipro Corporation (JP) Corporation Information
        7.3.2 Nipro Corporation (JP) Description and Business Overview
        7.3.3 Nipro Corporation (JP) Vial and Prefilled Syringe Sales, Revenue and Gross Margin (2017-2022)
        7.3.4 Nipro Corporation (JP) Vial and Prefilled Syringe Products Offered
        7.3.5 Nipro Corporation (JP) Recent Development
    7.4 Schott forma vitrum (DE)
        7.4.1 Schott forma vitrum (DE) Corporation Information
        7.4.2 Schott forma vitrum (DE) Description and Business Overview
        7.4.3 Schott forma vitrum (DE) Vial and Prefilled Syringe Sales, Revenue and Gross Margin (2017-2022)
        7.4.4 Schott forma vitrum (DE) Vial and Prefilled Syringe Products Offered
        7.4.5 Schott forma vitrum (DE) Recent Development
    7.5 Ompi (IT)
        7.5.1 Ompi (IT) Corporation Information
        7.5.2 Ompi (IT) Description and Business Overview
        7.5.3 Ompi (IT) Vial and Prefilled Syringe Sales, Revenue and Gross Margin (2017-2022)
        7.5.4 Ompi (IT) Vial and Prefilled Syringe Products Offered
        7.5.5 Ompi (IT) Recent Development
    7.6 Baxter BioPharma Solution (US)
        7.6.1 Baxter BioPharma Solution (US) Corporation Information
        7.6.2 Baxter BioPharma Solution (US) Description and Business Overview
        7.6.3 Baxter BioPharma Solution (US) Vial and Prefilled Syringe Sales, Revenue and Gross Margin (2017-2022)
        7.6.4 Baxter BioPharma Solution (US) Vial and Prefilled Syringe Products Offered
        7.6.5 Baxter BioPharma Solution (US) Recent Development
    7.7 ROVI CM (ES)
        7.7.1 ROVI CM (ES) Corporation Information
        7.7.2 ROVI CM (ES) Description and Business Overview
        7.7.3 ROVI CM (ES) Vial and Prefilled Syringe Sales, Revenue and Gross Margin (2017-2022)
        7.7.4 ROVI CM (ES) Vial and Prefilled Syringe Products Offered
        7.7.5 ROVI CM (ES) Recent Development
    7.8 Terumo (JP)
        7.8.1 Terumo (JP) Corporation Information
        7.8.2 Terumo (JP) Description and Business Overview
        7.8.3 Terumo (JP) Vial and Prefilled Syringe Sales, Revenue and Gross Margin (2017-2022)
        7.8.4 Terumo (JP) Vial and Prefilled Syringe Products Offered
        7.8.5 Terumo (JP) Recent Development
    7.9 Vetter (DE)
        7.9.1 Vetter (DE) Corporation Information
        7.9.2 Vetter (DE) Description and Business Overview
        7.9.3 Vetter (DE) Vial and Prefilled Syringe Sales, Revenue and Gross Margin (2017-2022)
        7.9.4 Vetter (DE) Vial and Prefilled Syringe Products Offered
        7.9.5 Vetter (DE) Recent Development
    7.10 Unilife Corporation (US)
        7.10.1 Unilife Corporation (US) Corporation Information
        7.10.2 Unilife Corporation (US) Description and Business Overview
        7.10.3 Unilife Corporation (US) Vial and Prefilled Syringe Sales, Revenue and Gross Margin (2017-2022)
        7.10.4 Unilife Corporation (US) Vial and Prefilled Syringe Products Offered
        7.10.5 Unilife Corporation (US) Recent Development
    7.11 Taisei Kako (JP)
        7.11.1 Taisei Kako (JP) Corporation Information
        7.11.2 Taisei Kako (JP) Description and Business Overview
        7.11.3 Taisei Kako (JP) Vial and Prefilled Syringe Sales, Revenue and Gross Margin (2017-2022)
        7.11.4 Taisei Kako (JP) Vial and Prefilled Syringe Products Offered
        7.11.5 Taisei Kako (JP) Recent Development
    7.12 Roselabs Group (IN)
        7.12.1 Roselabs Group (IN) Corporation Information
        7.12.2 Roselabs Group (IN) Description and Business Overview
        7.12.3 Roselabs Group (IN) Vial and Prefilled Syringe Sales, Revenue and Gross Margin (2017-2022)
        7.12.4 Roselabs Group (IN) Products Offered
        7.12.5 Roselabs Group (IN) Recent Development
    7.13 ARTE CORPORATION (JP)
        7.13.1 ARTE CORPORATION (JP) Corporation Information
        7.13.2 ARTE CORPORATION (JP) Description and Business Overview
        7.13.3 ARTE CORPORATION (JP) Vial and Prefilled Syringe Sales, Revenue and Gross Margin (2017-2022)
        7.13.4 ARTE CORPORATION (JP) Products Offered
        7.13.5 ARTE CORPORATION (JP) Recent Development
    7.14 Weigao Group Medical Polymer (CN)
        7.14.1 Weigao Group Medical Polymer (CN) Corporation Information
        7.14.2 Weigao Group Medical Polymer (CN) Description and Business Overview
        7.14.3 Weigao Group Medical Polymer (CN) Vial and Prefilled Syringe Sales, Revenue and Gross Margin (2017-2022)
        7.14.4 Weigao Group Medical Polymer (CN) Products Offered
        7.14.5 Weigao Group Medical Polymer (CN) Recent Development
    7.15 Zibo Minkang Pharmaceutical (CN)
        7.15.1 Zibo Minkang Pharmaceutical (CN) Corporation Information
        7.15.2 Zibo Minkang Pharmaceutical (CN) Description and Business Overview
        7.15.3 Zibo Minkang Pharmaceutical (CN) Vial and Prefilled Syringe Sales, Revenue and Gross Margin (2017-2022)
        7.15.4 Zibo Minkang Pharmaceutical (CN) Products Offered
        7.15.5 Zibo Minkang Pharmaceutical (CN) Recent Development
    7.16 Shandong Pharmaceutical Glass (CN)
        7.16.1 Shandong Pharmaceutical Glass (CN) Corporation Information
        7.16.2 Shandong Pharmaceutical Glass (CN) Description and Business Overview
        7.16.3 Shandong Pharmaceutical Glass (CN) Vial and Prefilled Syringe Sales, Revenue and Gross Margin (2017-2022)
        7.16.4 Shandong Pharmaceutical Glass (CN) Products Offered
        7.16.5 Shandong Pharmaceutical Glass (CN) Recent Development
8 Industry Chain and Sales Channels Analysis
    8.1 Vial and Prefilled Syringe Industry Chain Analysis
    8.2 Vial and Prefilled Syringe Key Raw Materials
        8.2.1 Key Raw Materials
        8.2.2 Vial and Prefilled Syringe Distributors
    8.3 Vial and Prefilled Syringe Production Mode & Process
    8.4 Vial and Prefilled Syringe Sales and Marketing
        8.4.1 Vial and Prefilled Syringe Sales Channels
        8.4.2 Vial and Prefilled Syringe Distributors
    8.5 Vial and Prefilled Syringe Customers
9 Research Findings and Conclusion
10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer
List of Tables
    Table 1. Vial and Prefilled Syringe CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Vial and Prefilled Syringe Market Trends
    Table 3. Vial and Prefilled Syringe Market Drivers
    Table 4. Vial and Prefilled Syringe Market Challenges
    Table 5. Vial and Prefilled Syringe Market Restraints
    Table 6. Global Vial and Prefilled Syringe Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Vial and Prefilled Syringe Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Vial and Prefilled Syringe Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Vial and Prefilled Syringe Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Vial and Prefilled Syringe Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Vial and Prefilled Syringe Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Vial and Prefilled Syringe Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Vial and Prefilled Syringe Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Vial and Prefilled Syringe Sales Share by Manufacturer, 2017-2022
    Table 15. Global Vial and Prefilled Syringe Price by Manufacturer (2017-2022) & (USD/Unit)
    Table 16. Global Vial and Prefilled Syringe Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Vial and Prefilled Syringe by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vial and Prefilled Syringe as of 2021)
    Table 18. Top Players of Vial and Prefilled Syringe in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Vial and Prefilled Syringe Product Type
    Table 20. Date of International Manufacturers Enter into Vial and Prefilled Syringe Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Vial and Prefilled Syringe Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Vial and Prefilled Syringe Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Vial and Prefilled Syringe Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Vial and Prefilled Syringe Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Vial and Prefilled Syringe Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Vial and Prefilled Syringe Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Vial and Prefilled Syringe Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Vial and Prefilled Syringe Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Vial and Prefilled Syringe Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Vial and Prefilled Syringe Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Vial and Prefilled Syringe Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Vial and Prefilled Syringe Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Vial and Prefilled Syringe Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Vial and Prefilled Syringe Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Vial and Prefilled Syringe Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Vial and Prefilled Syringe Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Vial and Prefilled Syringe Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Vial and Prefilled Syringe Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Vial and Prefilled Syringe Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Vial and Prefilled Syringe Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. BD (US) Corporation Information
    Table 43. BD (US) Description and Business Overview
    Table 44. BD (US) Vial and Prefilled Syringe Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 45. BD (US) Vial and Prefilled Syringe Product
    Table 46. BD (US) Recent Development
    Table 47. Gerresheimer (DE) Corporation Information
    Table 48. Gerresheimer (DE) Description and Business Overview
    Table 49. Gerresheimer (DE) Vial and Prefilled Syringe Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 50. Gerresheimer (DE) Product
    Table 51. Gerresheimer (DE) Recent Development
    Table 52. Nipro Corporation (JP) Corporation Information
    Table 53. Nipro Corporation (JP) Description and Business Overview
    Table 54. Nipro Corporation (JP) Vial and Prefilled Syringe Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 55. Nipro Corporation (JP) Product
    Table 56. Nipro Corporation (JP) Recent Development
    Table 57. Schott forma vitrum (DE) Corporation Information
    Table 58. Schott forma vitrum (DE) Description and Business Overview
    Table 59. Schott forma vitrum (DE) Vial and Prefilled Syringe Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 60. Schott forma vitrum (DE) Product
    Table 61. Schott forma vitrum (DE) Recent Development
    Table 62. Ompi (IT) Corporation Information
    Table 63. Ompi (IT) Description and Business Overview
    Table 64. Ompi (IT) Vial and Prefilled Syringe Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 65. Ompi (IT) Product
    Table 66. Ompi (IT) Recent Development
    Table 67. Baxter BioPharma Solution (US) Corporation Information
    Table 68. Baxter BioPharma Solution (US) Description and Business Overview
    Table 69. Baxter BioPharma Solution (US) Vial and Prefilled Syringe Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 70. Baxter BioPharma Solution (US) Product
    Table 71. Baxter BioPharma Solution (US) Recent Development
    Table 72. ROVI CM (ES) Corporation Information
    Table 73. ROVI CM (ES) Description and Business Overview
    Table 74. ROVI CM (ES) Vial and Prefilled Syringe Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 75. ROVI CM (ES) Product
    Table 76. ROVI CM (ES) Recent Development
    Table 77. Terumo (JP) Corporation Information
    Table 78. Terumo (JP) Description and Business Overview
    Table 79. Terumo (JP) Vial and Prefilled Syringe Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 80. Terumo (JP) Product
    Table 81. Terumo (JP) Recent Development
    Table 82. Vetter (DE) Corporation Information
    Table 83. Vetter (DE) Description and Business Overview
    Table 84. Vetter (DE) Vial and Prefilled Syringe Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 85. Vetter (DE) Product
    Table 86. Vetter (DE) Recent Development
    Table 87. Unilife Corporation (US) Corporation Information
    Table 88. Unilife Corporation (US) Description and Business Overview
    Table 89. Unilife Corporation (US) Vial and Prefilled Syringe Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 90. Unilife Corporation (US) Product
    Table 91. Unilife Corporation (US) Recent Development
    Table 92. Taisei Kako (JP) Corporation Information
    Table 93. Taisei Kako (JP) Description and Business Overview
    Table 94. Taisei Kako (JP) Vial and Prefilled Syringe Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 95. Taisei Kako (JP) Product
    Table 96. Taisei Kako (JP) Recent Development
    Table 97. Roselabs Group (IN) Corporation Information
    Table 98. Roselabs Group (IN) Description and Business Overview
    Table 99. Roselabs Group (IN) Vial and Prefilled Syringe Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 100. Roselabs Group (IN) Product
    Table 101. Roselabs Group (IN) Recent Development
    Table 102. ARTE CORPORATION (JP) Corporation Information
    Table 103. ARTE CORPORATION (JP) Description and Business Overview
    Table 104. ARTE CORPORATION (JP) Vial and Prefilled Syringe Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 105. ARTE CORPORATION (JP) Product
    Table 106. ARTE CORPORATION (JP) Recent Development
    Table 107. Weigao Group Medical Polymer (CN) Corporation Information
    Table 108. Weigao Group Medical Polymer (CN) Description and Business Overview
    Table 109. Weigao Group Medical Polymer (CN) Vial and Prefilled Syringe Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 110. Weigao Group Medical Polymer (CN) Product
    Table 111. Weigao Group Medical Polymer (CN) Recent Development
    Table 112. Zibo Minkang Pharmaceutical (CN) Corporation Information
    Table 113. Zibo Minkang Pharmaceutical (CN) Description and Business Overview
    Table 114. Zibo Minkang Pharmaceutical (CN) Vial and Prefilled Syringe Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 115. Zibo Minkang Pharmaceutical (CN) Product
    Table 116. Zibo Minkang Pharmaceutical (CN) Recent Development
    Table 117. Shandong Pharmaceutical Glass (CN) Corporation Information
    Table 118. Shandong Pharmaceutical Glass (CN) Description and Business Overview
    Table 119. Shandong Pharmaceutical Glass (CN) Vial and Prefilled Syringe Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 120. Shandong Pharmaceutical Glass (CN) Product
    Table 121. Shandong Pharmaceutical Glass (CN) Recent Development
    Table 122. Key Raw Materials Lists
    Table 123. Raw Materials Key Suppliers Lists
    Table 124. Vial and Prefilled Syringe Customers List
    Table 125. Vial and Prefilled Syringe Distributors List
    Table 126. Research Programs/Design for This Report
    Table 127. Key Data Information from Secondary Sources
    Table 128. Key Data Information from Primary Sources
List of Figures
    Figure 1. Vial and Prefilled Syringe Product Picture
    Figure 2. Global Vial and Prefilled Syringe Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Vial and Prefilled Syringe Market Size 2017-2028 (US$ Million)
    Figure 4. Global Vial and Prefilled Syringe Sales 2017-2028 (K Units)
    Figure 5. United States Vial and Prefilled Syringe Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Vial and Prefilled Syringe Market Size 2017-2028 (US$ Million)
    Figure 7. United States Vial and Prefilled Syringe Sales 2017-2028 (K Units)
    Figure 8. United States Vial and Prefilled Syringe Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Vial and Prefilled Syringe Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Vial and Prefilled Syringe Report Years Considered
    Figure 11. Product Picture of Glass Vial and Prefilled Syringe
    Figure 12. Product Picture of Polymer Vial and Prefilled Syringe
    Figure 13. Global Vial and Prefilled Syringe Market Share by Type in 2022 & 2028
    Figure 14. Global Vial and Prefilled Syringe Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 15. Global Vial and Prefilled Syringe Sales Market Share in Value by Type (2017-2028)
    Figure 16. Global Vial and Prefilled Syringe Sales by Type (2017-2028) & (K Units)
    Figure 17. Global Vial and Prefilled Syringe Sales Market Share in Volume by Type (2017-2028)
    Figure 18. Global Vial and Prefilled Syringe Price by Type (2017-2028) & (USD/Unit)
    Figure 19. United States Vial and Prefilled Syringe Market Share by Type in 2022 & 2028
    Figure 20. United States Vial and Prefilled Syringe Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 21. United States Vial and Prefilled Syringe Sales Market Share in Value by Type (2017-2028)
    Figure 22. United States Vial and Prefilled Syringe Sales by Type (2017-2028) & (K Units)
    Figure 23. United States Vial and Prefilled Syringe Sales Market Share in Volume by Type (2017-2028)
    Figure 24. United States Vial and Prefilled Syringe Price by Type (2017-2028) & (USD/Unit)
    Figure 25. Product Picture of Antithrombotics
    Figure 26. Product Picture of Vaccines
    Figure 27. Product Picture of Autoimmune Diseases
    Figure 28. Product Picture of Anti-inflammatory Drugs
    Figure 29. Product Picture of Others
    Figure 30. Global Vial and Prefilled Syringe Market Share by Application in 2022 & 2028
    Figure 31. Global Vial and Prefilled Syringe Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 32. Global Vial and Prefilled Syringe Sales Market Share in Value by Application (2017-2028)
    Figure 33. Global Vial and Prefilled Syringe Sales by Application (2017-2028) & (K Units)
    Figure 34. Global Vial and Prefilled Syringe Sales Market Share in Volume by Application (2017-2028)
    Figure 35. Global Vial and Prefilled Syringe Price by Application (2017-2028) & (USD/Unit)
    Figure 36. United States Vial and Prefilled Syringe Market Share by Application in 2022 & 2028
    Figure 37. United States Vial and Prefilled Syringe Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 38. United States Vial and Prefilled Syringe Sales Market Share in Value by Application (2017-2028)
    Figure 39. United States Vial and Prefilled Syringe Sales by Application (2017-2028) & (K Units)
    Figure 40. United States Vial and Prefilled Syringe Sales Market Share in Volume by Application (2017-2028)
    Figure 41. United States Vial and Prefilled Syringe Price by Application (2017-2028) & (USD/Unit)
    Figure 42. North America Vial and Prefilled Syringe Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 43. North America Vial and Prefilled Syringe Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 44. U.S. Vial and Prefilled Syringe Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Canada Vial and Prefilled Syringe Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Europe Vial and Prefilled Syringe Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 47. Europe Vial and Prefilled Syringe Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 48. Germany Vial and Prefilled Syringe Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. France Vial and Prefilled Syringe Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. U.K. Vial and Prefilled Syringe Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Italy Vial and Prefilled Syringe Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Russia Vial and Prefilled Syringe Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Asia-Pacific Vial and Prefilled Syringe Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 54. Asia-Pacific Vial and Prefilled Syringe Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 55. China Vial and Prefilled Syringe Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Japan Vial and Prefilled Syringe Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. South Korea Vial and Prefilled Syringe Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. India Vial and Prefilled Syringe Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Australia Vial and Prefilled Syringe Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. China Taiwan Vial and Prefilled Syringe Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Indonesia Vial and Prefilled Syringe Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Thailand Vial and Prefilled Syringe Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Malaysia Vial and Prefilled Syringe Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Latin America Vial and Prefilled Syringe Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 65. Latin America Vial and Prefilled Syringe Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 66. Mexico Vial and Prefilled Syringe Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Brazil Vial and Prefilled Syringe Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Argentina Vial and Prefilled Syringe Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Middle East & Africa Vial and Prefilled Syringe Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 70. Middle East & Africa Vial and Prefilled Syringe Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 71. Turkey Vial and Prefilled Syringe Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Saudi Arabia Vial and Prefilled Syringe Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. UAE Vial and Prefilled Syringe Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. Vial and Prefilled Syringe Value Chain
    Figure 75. Vial and Prefilled Syringe Production Process
    Figure 76. Channels of Distribution
    Figure 77. Distributors Profiles
    Figure 78. Bottom-up and Top-down Approaches for This Report
    Figure 79. Data Triangulation
    Figure 80. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
BD (US)
Gerresheimer (DE)
Nipro Corporation (JP)
Schott forma vitrum (DE)
Ompi (IT)
Baxter BioPharma Solution (US)
ROVI CM (ES)
Terumo (JP)
Vetter (DE)
Unilife Corporation (US)
Taisei Kako (JP)
Roselabs Group (IN)
ARTE CORPORATION (JP)
Weigao Group Medical Polymer (CN)
Zibo Minkang Pharmaceutical (CN)
Shandong Pharmaceutical Glass (CN)
Frequently Asked Questions
Vial and Prefilled Syringe report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Vial and Prefilled Syringe report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Vial and Prefilled Syringe report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Walking Canes

Walking Canes market is segmented by region (country), players, by Type and by Application. Playe ... Read More